Sumatriptan and Naproxen Sodium is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Aurobindo Pharma Limited. The primary component is Sumatriptan Succinate; Naproxen Sodium.
| Product ID | 65862-928_2cac6b99-d569-4bd7-9cc7-f53a75401514 |
| NDC | 65862-928 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sumatriptan and Naproxen Sodium |
| Generic Name | Sumatriptan And Naproxen Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-02-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207457 |
| Labeler Name | Aurobindo Pharma Limited |
| Substance Name | SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM |
| Active Ingredient Strength | 85 mg/1; mg/1 |
| Pharm Classes | Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2018-02-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA207457 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-02-15 |
| Ingredient | Strength |
|---|---|
| SUMATRIPTAN SUCCINATE | 85 mg/1 |
| SPL SET ID: | f5203c66-0a40-4263-a237-b71e930e4697 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0378-8755 | Sumatriptan and Naproxen Sodium | sumatriptan and naproxen sodium |
| 16714-891 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |
| 47335-410 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |
| 65862-928 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |
| 71800-901 | Sumatriptan and Naproxen Sodium | Sumatriptan and Naproxen Sodium |